The HELPP Score: A Pretreatment Score to Predict Survival in Pancreatic Cancer

Recruiting now

Conditions studied: Pancreatic Adenocarcinoma

In brief

The goal of this observational study is to validate a pretreatment prognostic score (Heidelberg Prognostic Pancreatic Cancer Score - HELPP) in patients with pancreatic ductal adenocarcinoma. The main questions it aims to answer are: * Is the HELPP score able to predict median overall survival in a prospective multi-institutional cohort of patients with pretherapeutic localized non-metastatic pancreatic cancer? * Is the HELPP score able to predict median recurrence-free survival and patterns of recurrence after resection of pancreatic cancer?

Key facts

Study ID

NCT05752812

Run by

Medical University of Vienna

People needed

1500

Starts

2023-03-01

Expected to finish

2026-11-01

Last updated by the study team

2023-10-27

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• ≥18 years old
• fit to undergo elective pancreatic resection or palliative therapy
• localized non-metastatic pancreatic ductal adenocarcinoma
• informed consent provided

You may not qualify if…

• patients with a diagnosis other than pancreatic ductal adenocarcinoma on histopathology
• missing informed consent
• missing mandatory pretreatment laboratory values
• missing mandatory pretreatment clinicopathologic data
• patients receiving surgery for peripancreatic cancer
• incomplete follow-up records
• follow-up < 24 months
• pregnancy

Where it is running

• Department of General Surgery, Division of Visceral Surgery, Medical University of Vienna — Vienna, Austria (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.